News & Press Releases

Platform Technologies Emerge in Biopharma

We have noticed the emergence of an interesting trend that is popping up in the emerging biopharmaceutical industry: platform technologies, which differ from one company to the next. In Kleo’s case, platform technology essentially involves the engineering of antibodies and biologics using linear process chemistry to enhance drug effectiveness. In this interview, Doug Manion, CEO of Kleo, will explain.

Print Friendly, PDF & Email

Upcoming Events:

October 2020
No event found!